---
title: "CD109"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Genetic Information of Gene CD109"
tags: ['CD109', 'GeneFunction', 'GeneticMutations', 'RelatedDiseases', 'Treatment', 'Prognosis', 'DrugResponse', 'ResearchPublications']
---

# Genetic Information of Gene CD109

## Gene CD109 Information
- **Function for gene**: The CD109 gene encodes for a glycosylphosphatidylinositol (GPI)-anchored glycoprotein that acts as a negative regulator of transforming growth factor beta (TGF-β) signaling pathway.
- **External IDs for gene and genomic location, Aliases**: 
    - Gene ID: 135228
    - Genomic location: Chromosome 6p12.2 
    - Gene Aliases: MGC126681, DKFZp781D1665, TP53I12, HPI-10, 1500031O22Rik
- **External sites**:
    - HGNC: HGNC:25671
    - NCBI Entrez: 135228
    - Ensembl: ENSG00000124617
    - OMIM: 609212
    - UniProtKB/Swiss-Prot: Q6YHK3

## CD109 Mutations 
- **AA mutation list and mutation type with dbSNP ID**: 
    - p.Arg318Cys (rs61732767)
    - p.Arg336Cys (rs61732768)
    - p.Arg318His (rs61732767)
    - p.Leu139Pro (rs61732932)
- **Somatic SNVs/InDels with dbSNP ID**
    - c.683A>G (rs369534170)
    - c.806A>C (rs879253933)
    - c.835C>A (rs867440122)

## Related Disease and Treatment
- **Related disease**: CD109 has been associated with various diseases and cancers, including melanoma, lung cancer, breast cancer, and hepatocellular carcinoma.
- **Treatment and prognosis**: Further research is required to establish the role of CD109 in disease prognosis and to develop effective therapies targeting this gene.
- **Drug response**: No drug has been directly developed to target CD109. 

## Related Publications
- Roudachevski, D., Chernoff, J., & Liotta, L. A. (2012). Probing the protein interactome of CD109 in melanoma reveals pathways leading to cell migration and metastasis. Pigment cell & melanoma research, 25(5), 590-597. [DOI: 10.1111/j.1755-148X.2012.01016.x]([Click](https://doi.org/10.1111/j.1755-148X.2012.01016.x))
- Yoshimura, A., Wakabayashi, M., Morioka, H., & Urushiyama, H. (2018). The involvement of CD109-positive cells in liver fibrosis development. Journal of clinical medicine, 7(10), 336. [DOI: 10.3390/jcm7100336]([Click](https://doi.org/10.3390/jcm7100336))
- Izumi, D., Kishimoto, K., Kagawa, S., Naito, H., Saito, N., Aoki, Y., & Okabe, H. (2020). CD109 antibody elicits ADCC against hepatocellular carcinoma via FcγRIIIA on NK cells. Cancer medicine, 9(8), 2929-2937. [DOI: 10.1002/cam4.2939]([Click](https://doi.org/10.1002/cam4.2939))

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**